For BPC-157 specifically, the FDA reported limited and short human studies, a lack of adequate studies for several commonly used routes of administration, potential immunogenicity concerns, possible liver and clotting signals in animal studies, and three adverse-event reports, while noting that a cause could not be established
BPC-157 creates the conditions for healing (blood vessels, growth factors), and TB-500 mobilizes the cells that do the actual repair
Ca 2+ acts as a key second messenger in regulating various physiological changes during capacitation, including hyperactivation of motility (Snchez-Crdenas et al., 2018), membrane fluidity alterations, and the activation of signaling cascades essential for the acrosome reaction (Buffone et al., 2014)
Ilic S, Brcic I, Mester M, et al
Therefore, it's advisable to consult a healthcare professional before use